Pacira BioSciences, Inc. financial data

Symbol
PCRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
5401 West Kennedy Boulevard, Suite 890, Tampa, Florida
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Pacira Pharmaceuticals, Inc. (to 4/9/2019), PACIRA INC (to 11/5/2008), Blue Acquisition Corp (to 4/16/2007)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 491 % +29.6%
Quick Ratio 99.1 % +31.1%
Debt-to-equity 83.3 % -29.1%
Return On Equity 8.29 %
Return On Assets 4.52 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.5M shares +1.11%
Common Stock, Shares, Outstanding 46.5M shares +1.19%
Entity Public Float 1.3B USD -31.6%
Common Stock, Value, Issued 47K USD +2.17%
Weighted Average Number of Shares Outstanding, Basic 46.5M shares +1.2%
Weighted Average Number of Shares Outstanding, Diluted 52.2M shares +13.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 682M USD +1.88%
Cost of Revenue 183M USD -13.7%
Research and Development Expense 77.4M USD -3.71%
Costs and Expenses 578M USD -8.24%
Operating Income (Loss) 104M USD +163%
Nonoperating Income (Expense) -2.16M USD +96.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 102M USD
Income Tax Expense (Benefit) 31.3M USD
Net Income (Loss) Attributable to Parent 70.5M USD
Earnings Per Share, Basic 1.53 USD/shares
Earnings Per Share, Diluted 1.51 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 184M USD +418%
Accounts Receivable, after Allowance for Credit Loss, Current 102M USD +9.05%
Inventory, Net 96.8M USD +4.09%
Assets, Current 543M USD +44.4%
Deferred Income Tax Assets, Net 141M USD -15.8%
Property, Plant and Equipment, Net 172M USD -5.4%
Operating Lease, Right-of-Use Asset 58.6M USD -13.9%
Intangible Assets, Net (Excluding Goodwill) 469M USD -10.9%
Goodwill 163M USD 0%
Assets 1.58B USD +3.93%
Accounts Payable, Current 8.98M USD -48%
Employee-related Liabilities, Current 21.7M USD -17.2%
Accrued Liabilities, Current 66.8M USD +8.41%
Liabilities, Current 93.4M USD -5.32%
Contract with Customer, Liability, Noncurrent 10.1M USD
Operating Lease, Liability, Noncurrent 52.4M USD -16%
Other Liabilities, Noncurrent 12.7M USD +9.6%
Liabilities 691M USD -8.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 152K USD
Retained Earnings (Accumulated Deficit) -97.8M USD +41.9%
Stockholders' Equity Attributable to Parent 892M USD +16.2%
Liabilities and Equity 1.58B USD +3.93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 49.1M USD +157%
Net Cash Provided by (Used in) Financing Activities -2.82M USD +98.2%
Net Cash Provided by (Used in) Investing Activities -15.5M USD -123%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 46.5M shares +1.19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 30.8M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 184M USD +418%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.97M USD -77.5%
Deferred Tax Assets, Valuation Allowance 25.5M USD +11.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 212M USD -10.9%
Operating Lease, Liability 61.4M USD -13.9%
Depreciation 17.1M USD -49.4%
Payments to Acquire Property, Plant, and Equipment 2.84M USD -56.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 70.8M USD
Lessee, Operating Lease, Liability, to be Paid 75.3M USD -16.3%
Property, Plant and Equipment, Gross 292M USD -4.09%
Operating Lease, Liability, Current 9M USD +0.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.8M USD -2.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.8M USD -8.28%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 3.46M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.9M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.6M USD -1.77%
Deferred Tax Assets, Operating Loss Carryforwards 132M USD -12.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 16.8M USD
Current Income Tax Expense (Benefit) 4.13M USD -22.6%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 6.71M USD +6.15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.9M USD -13.2%
Operating Lease, Payments 3.22M USD -14.5%
Additional Paid in Capital 990M USD +5.7%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2.44M USD -54%
Current Federal Tax Expense (Benefit) 1.69M USD
Amortization of Intangible Assets 57.3M USD 0%
Depreciation, Depletion and Amortization 18.4M USD -6%
Deferred Tax Assets, Net of Valuation Allowance 144M USD -9.87%
Share-based Payment Arrangement, Expense 49.1M USD +0.33%
Deferred State and Local Income Tax Expense (Benefit) -1.18M USD +77.2%
Interest Expense 14M USD -64.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%